Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.24
-0.52 (-6.70%)
Feb 10, 2026, 2:14 PM HKT

Wuhan YZY Biopharma Revenue

Wuhan YZY Biopharma had revenue of 44.37M CNY in the half year ending June 30, 2025, with 558.59% growth. This brings the company's revenue in the last twelve months to 149.35M. In the year 2024, Wuhan YZY Biopharma had annual revenue of 107.81M.

Revenue (ttm)
149.35M CNY
Revenue Growth
n/a
P/S Ratio
8.58
Revenue / Employee
1.41M CNY
Employees
106
Market Cap
1.40B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024107.81M--
Dec 31, 2023---
Dec 31, 20222.28M-9.89M-81.28%
Dec 31, 202112.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition